APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decitabine for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Decitabine for Injection Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchDecitabine for Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Decitabine for Injection Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Decitabine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decitabine for Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Decitabine for Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Decitabine for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Decitabine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Decitabine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Decitabine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Decitabine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Decitabine for Injection include Astex Pharmaceuticals, Hansoh Pharmaceutical, Ingenus Pharmaceutical, Meitheal Pharmaceuticals, Otsuka US, Sagent Pharmaceuticals, Huiyu Pharmaceutical, Qilu Pharmaceutical and Xian Janssen Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Decitabine for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Decitabine for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Decitabine for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Decitabine for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Decitabine for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Decitabine for Injection sales, projected growth trends, production technology, application and end-user industry.

Decitabine for Injection Segment by Company

Astex Pharmaceuticals

Hansoh Pharmaceutical

Ingenus Pharmaceutical

Meitheal Pharmaceuticals

Otsuka US

Sagent Pharmaceuticals

Huiyu Pharmaceutical

Qilu Pharmaceutical

Xian Janssen Pharmaceutical

Chia Tai Tianqing Pharmaceutical Group

Decitabine for Injection Segment by Type

50mg/Bottle

Other

Decitabine for Injection Segment by Application

Hospital

Clinic

Decitabine for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decitabine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decitabine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decitabine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Decitabine for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Decitabine for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decitabine for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Decitabine for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg/Bottle Major Manufacturers Table 3. Other Major Manufacturers Table 4. Global Decitabine for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Decitabine for Injection Industry Trends Table 8. Decitabine for Injection Industry Drivers Table 9. Decitabine for Injection Industry Opportunities and Challenges Table 10. Decitabine for Injection Industry Restraints Table 11. Global Decitabine for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Decitabine for Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Decitabine for Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Decitabine for Injection Revenue Market Share by Region (2021-2026) Table 15. Global Decitabine for Injection Revenue Market Share by Region (2027-2032) Table 16. Global Decitabine for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Decitabine for Injection Sales by Region (2021-2026) & (K Units) Table 18. Global Decitabine for Injection Sales by Region (2027-2032) & (K Units) Table 19. Global Decitabine for Injection Sales Market Share by Region (2021-2026) Table 20. Global Decitabine for Injection Sales Market Share by Region (2027-2032) Table 21. Global Decitabine for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Decitabine for Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Decitabine for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Decitabine for Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Decitabine for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Decitabine for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Decitabine for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Decitabine for Injection Manufacturers, Product Type & Application Table 29. Global Decitabine for Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Decitabine for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Decitabine for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Decitabine for Injection Revenue Market Share by Type (2021-2026) Table 36. Global Decitabine for Injection Revenue Market Share by Type (2027-2032) Table 37. Global Decitabine for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 39. Global Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 40. Global Decitabine for Injection Sales Market Share by Type (2021-2026) Table 41. Global Decitabine for Injection Sales Market Share by Type (2027-2032) Table 42. Global Decitabine for Injection Price by Type (2021-2026) & (US$/Unit) Table 43. Global Decitabine for Injection Price by Type (2027-2032) & (US$/Unit) Table 44. Global Decitabine for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Decitabine for Injection Revenue Market Share by Application (2021-2026) Table 48. Global Decitabine for Injection Revenue Market Share by Application (2027-2032) Table 49. Global Decitabine for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 51. Global Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 52. Global Decitabine for Injection Sales Market Share by Application (2021-2026) Table 53. Global Decitabine for Injection Sales Market Share by Application (2027-2032) Table 54. Global Decitabine for Injection Price by Application (2021-2026) & (US$/Unit) Table 55. Global Decitabine for Injection Price by Application (2027-2032) & (US$/Unit) Table 56. Astex Pharmaceuticals Company Information Table 57. Astex Pharmaceuticals Business Overview Table 58. Astex Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Astex Pharmaceuticals Decitabine for Injection Product Portfolio Table 60. Astex Pharmaceuticals Recent Development Table 61. Hansoh Pharmaceutical Company Information Table 62. Hansoh Pharmaceutical Business Overview Table 63. Hansoh Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Hansoh Pharmaceutical Decitabine for Injection Product Portfolio Table 65. Hansoh Pharmaceutical Recent Development Table 66. Ingenus Pharmaceutical Company Information Table 67. Ingenus Pharmaceutical Business Overview Table 68. Ingenus Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Ingenus Pharmaceutical Decitabine for Injection Product Portfolio Table 70. Ingenus Pharmaceutical Recent Development Table 71. Meitheal Pharmaceuticals Company Information Table 72. Meitheal Pharmaceuticals Business Overview Table 73. Meitheal Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Meitheal Pharmaceuticals Decitabine for Injection Product Portfolio Table 75. Meitheal Pharmaceuticals Recent Development Table 76. Otsuka US Company Information Table 77. Otsuka US Business Overview Table 78. Otsuka US Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Otsuka US Decitabine for Injection Product Portfolio Table 80. Otsuka US Recent Development Table 81. Sagent Pharmaceuticals Company Information Table 82. Sagent Pharmaceuticals Business Overview Table 83. Sagent Pharmaceuticals Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sagent Pharmaceuticals Decitabine for Injection Product Portfolio Table 85. Sagent Pharmaceuticals Recent Development Table 86. Huiyu Pharmaceutical Company Information Table 87. Huiyu Pharmaceutical Business Overview Table 88. Huiyu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Huiyu Pharmaceutical Decitabine for Injection Product Portfolio Table 90. Huiyu Pharmaceutical Recent Development Table 91. Qilu Pharmaceutical Company Information Table 92. Qilu Pharmaceutical Business Overview Table 93. Qilu Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Qilu Pharmaceutical Decitabine for Injection Product Portfolio Table 95. Qilu Pharmaceutical Recent Development Table 96. Xian Janssen Pharmaceutical Company Information Table 97. Xian Janssen Pharmaceutical Business Overview Table 98. Xian Janssen Pharmaceutical Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolio Table 100. Xian Janssen Pharmaceutical Recent Development Table 101. Chia Tai Tianqing Pharmaceutical Group Company Information Table 102. Chia Tai Tianqing Pharmaceutical Group Business Overview Table 103. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolio Table 105. Chia Tai Tianqing Pharmaceutical Group Recent Development Table 106. North America Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 109. North America Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 110. North America Decitabine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Decitabine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 115. North America Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 116. North America Decitabine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Decitabine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Decitabine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Decitabine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 122. North America Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 123. North America Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 124. North America Decitabine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Decitabine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 127. Canada Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 128. Mexico Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 129. Europe Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 132. Europe Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 133. Europe Decitabine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Decitabine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 138. Europe Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 139. Europe Decitabine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Decitabine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Decitabine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Decitabine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 146. Europe Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 147. Europe Decitabine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Decitabine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 150. France Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 151. U.K. Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 152. Italy Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 153. Russia Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 154. Spain Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 155. Netherlands Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 156. Switzerland Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 157. Sweden Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 158. Poland Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 159. China Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 160. China Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 161. China Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 162. China Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 163. China Decitabine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Decitabine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 166. China Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 167. China Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 168. China Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 169. China Decitabine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Decitabine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 174. Asia Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 175. Asia Decitabine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Decitabine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 180. Asia Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 181. Asia Decitabine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Decitabine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Decitabine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Decitabine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 188. Asia Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 189. Asia Decitabine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Decitabine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 192. South Korea Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 193. India Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 194. Australia Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 195. Taiwan Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Decitabine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Decitabine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Decitabine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Decitabine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Decitabine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Decitabine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Decitabine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Decitabine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Decitabine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Decitabine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Decitabine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Decitabine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 218. Argentina Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 219. Chile Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 220. Colombia Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 221. Peru Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 223. Israel Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 224. UAE Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 225. Turkey Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 226. Iran Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 227. Egypt Decitabine for Injection Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Decitabine for Injection Distributors List Table 231. Decitabine for Injection Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Decitabine for Injection Image Figure 2. Global Decitabine for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decitabine for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg/Bottle Image Figure 5. Other Image Figure 6. Global Decitabine for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Decitabine for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Decitabine for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Decitabine for Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Decitabine for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Decitabine for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Decitabine for Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Decitabine for Injection Sales (2021-2032) & (K Units) Figure 16. Global Decitabine for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Decitabine for Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Decitabine for Injection Sales YoY (2021-2032) & (K Units) Figure 19. Europe Decitabine for Injection Sales YoY (2021-2032) & (K Units) Figure 20. China Decitabine for Injection Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Decitabine for Injection Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Decitabine for Injection Sales YoY (2021-2032) & (K Units) Figure 23. Global Decitabine for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Decitabine for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Decitabine for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Decitabine for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Decitabine for Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Decitabine for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Decitabine for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Decitabine for Injection Sales Market Share by Type (2021-2032) Figure 32. Global Decitabine for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Decitabine for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Decitabine for Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Decitabine for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Decitabine for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Decitabine for Injection Sales Market Share by Application (2021-2032) Figure 38. North America Decitabine for Injection Revenue Share by Type (2021-2032) Figure 39. North America Decitabine for Injection Sales Share by Type (2021-2032) Figure 40. North America Decitabine for Injection Revenue Share by Application (2021-2032) Figure 41. North America Decitabine for Injection Sales Share by Application (2021-2032) Figure 42. North America Decitabine for Injection Revenue Share by Country (2021-2032) Figure 43. North America Decitabine for Injection Sales Share by Country (2021-2032) Figure 44. Europe Decitabine for Injection Revenue Share by Type (2021-2032) Figure 45. Europe Decitabine for Injection Sales Share by Type (2021-2032) Figure 46. Europe Decitabine for Injection Revenue Share by Application (2021-2032) Figure 47. Europe Decitabine for Injection Sales Share by Application (2021-2032) Figure 48. Europe Decitabine for Injection Revenue Share by Country (2021-2032) Figure 49. Europe Decitabine for Injection Sales Share by Country (2021-2032) Figure 50. China Decitabine for Injection Revenue Share by Type (2021-2032) Figure 51. China Decitabine for Injection Sales Share by Type (2021-2032) Figure 52. China Decitabine for Injection Revenue Share by Application (2021-2032) Figure 53. China Decitabine for Injection Sales Share by Application (2021-2032) Figure 54. Asia Decitabine for Injection Revenue Share by Type (2021-2032) Figure 55. Asia Decitabine for Injection Sales Share by Type (2021-2032) Figure 56. Asia Decitabine for Injection Revenue Share by Application (2021-2032) Figure 57. Asia Decitabine for Injection Sales Share by Application (2021-2032) Figure 58. Asia Decitabine for Injection Revenue Share by Country (2021-2032) Figure 59. Asia Decitabine for Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Decitabine for Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Decitabine for Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Decitabine for Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Decitabine for Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Decitabine for Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Decitabine for Injection Sales Share by Country (2021-2032) Figure 66. Decitabine for Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Decitabine for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/Bottle
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Astex Pharmaceuticals
  • Hansoh Pharmaceutical
  • Ingenus Pharmaceutical
  • Meitheal Pharmaceuticals
  • Otsuka US
  • Sagent Pharmaceuticals
  • Huiyu Pharmaceutical
  • Qilu Pharmaceutical
  • Xian Janssen Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Decitabine for Injection Market by Type
  3. 1.2.1 Global Decitabine for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg/Bottle
  5. 1.2.3 Other
  6. 1.3 Decitabine for Injection Market by Application
  7. 1.3.1 Global Decitabine for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Decitabine for Injection Market Dynamics
  1. 2.1 Decitabine for Injection Industry Trends
  2. 2.2 Decitabine for Injection Industry Drivers
  3. 2.3 Decitabine for Injection Industry Opportunities and Challenges
  4. 2.4 Decitabine for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Decitabine for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Decitabine for Injection Revenue by Region
  3. 3.2.1 Global Decitabine for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Decitabine for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Decitabine for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Decitabine for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Decitabine for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Decitabine for Injection Sales by Region
  9. 3.4.1 Global Decitabine for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Decitabine for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Decitabine for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Decitabine for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Decitabine for Injection Revenue by Manufacturers
  2. 4.1.1 Global Decitabine for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Decitabine for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Decitabine for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Decitabine for Injection Sales by Manufacturers
  6. 4.2.1 Global Decitabine for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Decitabine for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Decitabine for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Decitabine for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Decitabine for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Decitabine for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Decitabine for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Decitabine for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Decitabine for Injection Market CR5 and HHI
  16. 4.8.2 2025 Decitabine for Injection Tier 1, Tier 2, and Tier 3
5 Decitabine for Injection Market by Type
  1. 5.1 Global Decitabine for Injection Revenue by Type
  2. 5.1.1 Global Decitabine for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Decitabine for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Decitabine for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Decitabine for Injection Sales by Type
  6. 5.2.1 Global Decitabine for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Decitabine for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Decitabine for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Decitabine for Injection Price by Type
6 Decitabine for Injection Market by Application
  1. 6.1 Global Decitabine for Injection Revenue by Application
  2. 6.1.1 Global Decitabine for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Decitabine for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Decitabine for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Decitabine for Injection Sales by Application
  6. 6.2.1 Global Decitabine for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Decitabine for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Decitabine for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Decitabine for Injection Price by Application
7 Company Profiles
  1. 7.1 Astex Pharmaceuticals
  2. 7.1.1 Astex Pharmaceuticals Company Information
  3. 7.1.2 Astex Pharmaceuticals Business Overview
  4. 7.1.3 Astex Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Astex Pharmaceuticals Decitabine for Injection Product Portfolio
  6. 7.1.5 Astex Pharmaceuticals Recent Developments
  7. 7.2 Hansoh Pharmaceutical
  8. 7.2.1 Hansoh Pharmaceutical Company Information
  9. 7.2.2 Hansoh Pharmaceutical Business Overview
  10. 7.2.3 Hansoh Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Hansoh Pharmaceutical Decitabine for Injection Product Portfolio
  12. 7.2.5 Hansoh Pharmaceutical Recent Developments
  13. 7.3 Ingenus Pharmaceutical
  14. 7.3.1 Ingenus Pharmaceutical Company Information
  15. 7.3.2 Ingenus Pharmaceutical Business Overview
  16. 7.3.3 Ingenus Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ingenus Pharmaceutical Decitabine for Injection Product Portfolio
  18. 7.3.5 Ingenus Pharmaceutical Recent Developments
  19. 7.4 Meitheal Pharmaceuticals
  20. 7.4.1 Meitheal Pharmaceuticals Company Information
  21. 7.4.2 Meitheal Pharmaceuticals Business Overview
  22. 7.4.3 Meitheal Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Meitheal Pharmaceuticals Decitabine for Injection Product Portfolio
  24. 7.4.5 Meitheal Pharmaceuticals Recent Developments
  25. 7.5 Otsuka US
  26. 7.5.1 Otsuka US Company Information
  27. 7.5.2 Otsuka US Business Overview
  28. 7.5.3 Otsuka US Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Otsuka US Decitabine for Injection Product Portfolio
  30. 7.5.5 Otsuka US Recent Developments
  31. 7.6 Sagent Pharmaceuticals
  32. 7.6.1 Sagent Pharmaceuticals Company Information
  33. 7.6.2 Sagent Pharmaceuticals Business Overview
  34. 7.6.3 Sagent Pharmaceuticals Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sagent Pharmaceuticals Decitabine for Injection Product Portfolio
  36. 7.6.5 Sagent Pharmaceuticals Recent Developments
  37. 7.7 Huiyu Pharmaceutical
  38. 7.7.1 Huiyu Pharmaceutical Company Information
  39. 7.7.2 Huiyu Pharmaceutical Business Overview
  40. 7.7.3 Huiyu Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Huiyu Pharmaceutical Decitabine for Injection Product Portfolio
  42. 7.7.5 Huiyu Pharmaceutical Recent Developments
  43. 7.8 Qilu Pharmaceutical
  44. 7.8.1 Qilu Pharmaceutical Company Information
  45. 7.8.2 Qilu Pharmaceutical Business Overview
  46. 7.8.3 Qilu Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Qilu Pharmaceutical Decitabine for Injection Product Portfolio
  48. 7.8.5 Qilu Pharmaceutical Recent Developments
  49. 7.9 Xian Janssen Pharmaceutical
  50. 7.9.1 Xian Janssen Pharmaceutical Company Information
  51. 7.9.2 Xian Janssen Pharmaceutical Business Overview
  52. 7.9.3 Xian Janssen Pharmaceutical Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolio
  54. 7.9.5 Xian Janssen Pharmaceutical Recent Developments
  55. 7.10 Chia Tai Tianqing Pharmaceutical Group
  56. 7.10.1 Chia Tai Tianqing Pharmaceutical Group Company Information
  57. 7.10.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
  58. 7.10.3 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolio
  60. 7.10.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Decitabine for Injection Market Size by Type
  2. 8.1.1 North America Decitabine for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Decitabine for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Decitabine for Injection Price by Type (2021-2032)
  5. 8.2 North America Decitabine for Injection Market Size by Application
  6. 8.2.1 North America Decitabine for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Decitabine for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Decitabine for Injection Price by Application (2021-2032)
  9. 8.3 North America Decitabine for Injection Market Size by Country
  10. 8.3.1 North America Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Decitabine for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Decitabine for Injection Market Size by Type
  2. 9.1.1 Europe Decitabine for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Decitabine for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Decitabine for Injection Price by Type (2021-2032)
  5. 9.2 Europe Decitabine for Injection Market Size by Application
  6. 9.2.1 Europe Decitabine for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Decitabine for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Decitabine for Injection Price by Application (2021-2032)
  9. 9.3 Europe Decitabine for Injection Market Size by Country
  10. 9.3.1 Europe Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Decitabine for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Decitabine for Injection Market Size by Type
  2. 10.1.1 China Decitabine for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Decitabine for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Decitabine for Injection Price by Type (2021-2032)
  5. 10.2 China Decitabine for Injection Market Size by Application
  6. 10.2.1 China Decitabine for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Decitabine for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Decitabine for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Decitabine for Injection Market Size by Type
  2. 11.1.1 Asia Decitabine for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Decitabine for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Decitabine for Injection Price by Type (2021-2032)
  5. 11.2 Asia Decitabine for Injection Market Size by Application
  6. 11.2.1 Asia Decitabine for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Decitabine for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Decitabine for Injection Price by Application (2021-2032)
  9. 11.3 Asia Decitabine for Injection Market Size by Country
  10. 11.3.1 Asia Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Decitabine for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Decitabine for Injection Market Size by Type
  2. 12.1.1 SAMEA Decitabine for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Decitabine for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Decitabine for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Decitabine for Injection Market Size by Application
  6. 12.2.1 SAMEA Decitabine for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Decitabine for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Decitabine for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Decitabine for Injection Market Size by Country
  10. 12.3.1 SAMEA Decitabine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Decitabine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Decitabine for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Decitabine for Injection Value Chain Analysis
  2. 13.1.1 Decitabine for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Decitabine for Injection Production Mode & Process
  6. 13.2 Decitabine for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Decitabine for Injection Distributors
  9. 13.2.3 Decitabine for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst